A Selective Leukotriene B4 Antagonist, Acebilustat, for Treatment of Outpatients With COVID-19 Disease: A Randomized, Double-blind, Placebo-controlled Phase 2 Trial

J. E. Levitt,H. Hedlin,S. Duong, D. Lu,J. Lee, N. Elkarra,B. Pinsky, E. Heffernan, E. Springman, H. Bonilla,J. Parsonnet, R. T. Zamanian, J. Langguth,J. Bollyky,C. Khosla,M. R. Nicolls, M. Desai,R. Moss,A. Rogers

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE(2023)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要